Corona virus disease 2019Traditional Chinese medicineInflammationExudationPulmonary fibrosisAfter one-month of oral treatment with traditional Chinese medicine decoction,without using other drugs,the lung inflammatory exudate,pulmonary fibrosis and quality of life of a 61-year-old female patient with corona ...
Pulmonary-fibrosis (PF) is the result of interstitial lung disease which has different causes and it is one of the most intractable diseases in respiratory system. The PF is characterized by progressive difficulty of breath and dying of respiratory failure, seriously threatening the health of people...
Pulmonary fibrosis, sometimes known as “scarring of the lung”, is the name given to a group of chronic lung diseases. Read on to discover what exactly pulmonary fibrosis is, its symptoms and the treatment options available for this chronic lung disease. There are various different causes of ...
After one-month of oral treatment with traditional Chinese medicine decoction, without using other drugs, the lung inflammatory exudate, pulmonary fibrosis and quality of life of a 61-year-old female patient with corona virus disease 2019 (COVID-19) were significantly improved. No recurrence or de...
Introduction: Idiopathic pulmonary fibrosis (IPF) is a diffuse parenchymal lung disease with no cure. Up until recently, no treatment had been proven to alter its natural history as judged by rate of lung function decline. In 2014 however, the emergence of two novel anti-fibrotic agents, Pirfen...
iLeadBMS, affiliated with the Ildong Pharmaceutical Group, has unveiled promising research results for its novel idiopathic pulmonary fibrosis (IPF) treatment, IL1512, at the American Thoracic Society (ATS) 2024 conference, which is taking place in San D
Idiopathic pulmonary fibrosis (IPF) represents a particularly aggressive disease, the aetiology of which still remains unknown. The natural history of the disease often leads to respiratory failure and death, with a mortality rate greater than some cancers. To date, no management approach has proven...
"To our knowledge, this is the first direct evidence that Akt1 causes disease onset and progression ofpulmonary fibrosisandpulmonary hypertension," Shenoy said. "We have also tested this process in human cells taken from diseasedlung tissue, and we see very similar results." ...
MILAN ― Numerous unresolved questions surround progressive pulmonary fibrosis (PPF) treatment, according to Elisabeth Bendstrup, MD, PhD, a researcher and clinical professor in the Department of Clinical Medicine ― Department of Respiratory Diseases and Allergy, Aarhus University, Denmark. These ...
Learn about Esbriet® (pirfenidone), a medication for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and irreversible fibrotic interstitial lung disease. See full safety for more information.